Clinical Trial Update: Long-term Efficacy and Safety of V0034 CR 01B Cream in Patients With Moderate-to-severe Uremic Xerosis [Phase 3]

View source ↗

Summary

Phase 3 trial updates long-term efficacy and safety of V0034 CR 01B Cream in moderate-to-severe uremic xerosis; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uremic Xerosis

Drugs mentioned

• V0034 CR 01B Cream

Snippet

Sponsor: Orfagen | Conditions: Uremic Xerosis | Phase 3 | Status: COMPLETED | Results posted: 2014-03-18